EcoDrugPlus


Trade Names	GANITE
Synonyms	Gallium nitrate Gallium nitrate (anhydrous) Gallium nitrate anhydrous Gallium nitrate nonahydrate Ganite NSC-15200 Nitric acid, gallium salt
Status
Molecule Category	UNKNOWN
UNII	VRA0C6810N

Trade Names

GANITE

Synonyms

Gallium nitrate

Gallium nitrate (anhydrous)

Gallium nitrate anhydrous

Gallium nitrate nonahydrate

Ganite

NSC-15200

Nitric acid, gallium salt

Status

Molecule Category

UNKNOWN

UNII

VRA0C6810N


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Property Name	Value
Molecular Formula	GaN3O9
Molecular Weight	255.74
AlogP	None
Hydrogen Bond Acceptor	None
Hydrogen Bond Donor	None
Number of Rotational Bond	None
Polar Surface Area	None
Molecular species	None
Aromatic Rings	None
Heavy Atoms	None

Property Name

Value

Molecular Formula

GaN3O9

Molecular Weight

255.74

AlogP

None

Hydrogen Bond Acceptor

None

Hydrogen Bond Donor

None

Number of Rotational Bond

None

Polar Surface Area

None

Molecular species

None

Aromatic Rings

None

Heavy Atoms

None

Mechanism of Action	Action	Reference
Hydroxyapatite sequestering agent	SEQUESTERING AGENT	PubMed PubMed PubMed

Mechanism of Action

Action

Reference

Hydroxyapatite sequestering agent

SEQUESTERING AGENT

PubMed PubMed PubMed

Resources	Reference
ChEBI	29785
ChEMBL	CHEMBL1200983
DrugBank	DB05260
FDA SRS	VRA0C6810N
PDB	NO3
PubChem	5282394

Resources

Reference

ChEBI

ChEMBL

DrugBank

FDA SRS

PDB

PubChem


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

GALLIUM NITRATE

Physicochemical Descriptors

Bioactivity

Cross References